Forian Inc (FORA) Stock

About Forian Inc

Forian Inc. delivers advanced software solutions, proprietary data insights, and sophisticated predictive analytics. These offerings are designed to enhance the operational efficiency, clinical effectiveness, and financial stability of its diverse clientele, which spans the healthcare, cannabis, and government sectors. The company structures its operations into three primary segments: Information & Software, Services, and Other. Among its key product lines, Forian provides several critical tools for the cannabis industry. BioTrack is a comprehensive, vertically integrated software system that supports dispensaries, cultivators, manufacturers, and distributors with point-of-sale, production, and delivery management. Complementing this is Cannalytics, a Software as a Service (SaaS) analytics platform that offers clients a clear overview of their business performance. Furthermore, Forian offers robust compliance solutions like the BioTrack seed-to-sale platform, which facilitates the tracking and tracing of cannabis products from cultivation through to final sale. Its BioTrack State Traceability & Enforcement Monitoring System (STEMS) is specifically tailored for regulatory agencies, providing a module for cannabis program management and ensuring transparency and accountability across the supply chain. Beyond its core software and data offerings, Forian also extends its services to include security monitoring and web marketing. The company is based in Newtown, Pennsylvania.

Forian Inc is led by CEO Max C. Wygod, employs 47 people, headquartered in US, publicly traded since 2021.

Forian Inc (FORA) stock trades at $2.17 with a market capitalization of $67.79M. The stock is valued at a negative price-to-earnings (P/E) ratio of -24.11, reflecting a net loss over the last twelve months, price-to-book of 2.26, price-to-sales of 2.26. Over the past 52 weeks the stock has ranged between $1.64 and $2.71, and currently trades 19.9% below its 52-week high.

On profitability, Forian Inc generates a return on equity (ROE) of -10.00% (negative, reflecting a net loss), return on capital employed of -6.67%, an operating margin of -6.67%, a net profit margin of -17.00%.

Official website: forian.com

Forian Inc by the numbers, 2019–2025

Between 2019 and 2025 Forian Inc reported revenue of $0 rising to $30.0M. Compounded, revenue has grown 97.4% a year over five years, 23.3% over three, 50.0% over the last twelve months. Net profit fell to $-3.0M.

The most recent net margin is -17.00%. On a trailing twelve-month basis to Mar '26, revenue is $30.0M and net profit $-5.0M.

Borrowings stand at $0, cash from operations was $3.0M in the latest year, positive in 2 of the last 7.

Return on equity has averaged -61.7% over five years, and was -10.0% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Forian Inc (FORA) — frequently asked questions